Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 84

1.

Single-Cell Analysis of Crohn's Disease Lesions Identifies a Pathogenic Cellular Module Associated with Resistance to Anti-TNF Therapy.

Martin JC, Chang C, Boschetti G, Ungaro R, Giri M, Grout JA, Gettler K, Chuang LS, Nayar S, Greenstein AJ, Dubinsky M, Walker L, Leader A, Fine JS, Whitehurst CE, Mbow ML, Kugathasan S, Denson LA, Hyams JS, Friedman JR, Desai PT, Ko HM, Laface I, Akturk G, Schadt EE, Salmon H, Gnjatic S, Rahman AH, Merad M, Cho JH, Kenigsberg E.

Cell. 2019 Sep 5;178(6):1493-1508.e20. doi: 10.1016/j.cell.2019.08.008. Epub 2019 Aug 29.

PMID:
31474370
2.

Zebrafish modeling of intestinal injury, bacterial exposures and medications defines epithelial in vivo responses relevant to human inflammatory bowel disease.

Chuang LS, Morrison J, Hsu NY, Labrias PR, Nayar S, Chen E, Villaverde N, Facey JA, Boschetti G, Giri M, Castillo-Martin M, Thin TH, Sharma Y, Chu J, Cho JH.

Dis Model Mech. 2019 Aug 13;12(8). pii: dmm037432. doi: 10.1242/dmm.037432.

3.

Iron and manganese present in underground water promote biochemical, genotoxic, and behavioral alterations in zebrafish (Danio rerio).

Marins K, Lazzarotto LMV, Boschetti G, Bertoncello KT, Sachett A, Schindler MSZ, Chitolina R, Regginato A, Zanatta AP, Siebel AM, Magro JD, Zanatta L.

Environ Sci Pollut Res Int. 2019 Aug;26(23):23555-23570. doi: 10.1007/s11356-019-05621-0. Epub 2019 Jun 15.

PMID:
31203546
4.

TRIM33 deficiency in monocytes and macrophages impairs resolution of colonic inflammation.

Petit V, Parcelier A, Mathé C, Barroca V, Torres C, Lewandowski D, Ferri F, Gallouët AS, Dalloz M, Dinet O, Boschetti G, Vozenin MC, Roméo PH.

EBioMedicine. 2019 Jun;44:60-70. doi: 10.1016/j.ebiom.2019.05.037. Epub 2019 May 24.

5.

Concentrations of Ustekinumab During Induction Therapy Associate With Remission in Patients With Crohn's Disease.

Soufflet N, Boschetti G, Roblin X, Cuercq C, Williet N, Charlois AL, Duclaux-Loras R, Danion P, Mialon A, Faure M, Paul S, Flourie B, Nancey S.

Clin Gastroenterol Hepatol. 2019 Mar 6. pii: S1542-3565(19)30248-4. doi: 10.1016/j.cgh.2019.02.042. [Epub ahead of print]

PMID:
30851477
6.

Usefulness of confocal laser endomicroscopy for predicting postoperative recurrence in patients with Crohn's disease: a pilot study.

Auzoux J, Boschetti G, Anon B, Aubourg A, Caulet M, Poisson L, Besson P, Lecomte T, Roger S, Picon L, Nancey S, Moussata D, Flourie B.

Gastrointest Endosc. 2019 Jul;90(1):151-157. doi: 10.1016/j.gie.2019.02.030. Epub 2019 Mar 5.

PMID:
30849396
7.

Efficacy and Safety of Infliximab Tolerance Induction in Patients with Inflammatory Bowel Diseases who Experienced Acute Infusion Reactions.

Pauchard I, Nancey S, Hacard F, Williet N, Roblin X, Moussata D, Bérard F, Flourié B, Boschetti G.

Dig Dis. 2018;36(6):417-426. doi: 10.1159/000491078. Epub 2018 Aug 21.

PMID:
30130790
8.

High-dimensional immune phenotyping and transcriptional analyses reveal robust recovery of viable human immune and epithelial cells from frozen gastrointestinal tissue.

Konnikova L, Boschetti G, Rahman A, Mitsialis V, Lord J, Richmond C, Tomov VT, Gordon W, Jelinsky S, Canavan J, Liss A, Wall S, Field M, Zhou F, Goldsmith JD, Bewtra M, Breault DT, Merad M, Snapper SB.

Mucosal Immunol. 2018 Nov;11(6):1684-1693. doi: 10.1038/s41385-018-0047-y. Epub 2018 Aug 15.

9.

Soluble Mucosal Addressin Cell Adhesion Molecule 1 and Retinoic Acid are Potential Tools for Therapeutic Drug Monitoring in Patients with Inflammatory Bowel Disease Treated with Vedolizumab: A Proof of Concept Study.

Paul S, Williet N, Di Bernado T, Berger AE, Boschetti G, Filippi J, Del Tedesco E, Nancey S, Flourie B, Roblin X.

J Crohns Colitis. 2018 May 31. doi: 10.1093/ecco-jcc/jjy077. [Epub ahead of print]

PMID:
29860366
10.

Diabetic foot management: multidisciplinary approach for advanced lesion rescue.

Brocco E, Ninkovic S, Marin M, Whisstock C, Bruseghin M, Boschetti G, Viti R, Forlini W, Volpe A.

J Cardiovasc Surg (Torino). 2018 Oct;59(5):670-684. doi: 10.23736/S0021-9509.18.10606-9. Epub 2018 May 29. Review.

11.

Is the Pharmacokinetic Profile of a First Anti-TNF Predictive of the Clinical Outcome and Pharmacokinetics of a Second Anti-TNF?

Roblin X, Vérot C, Paul S, Duru G, Williet N, Boschetti G, Del Tedesco E, Peyrin-Biroulet L, Marc Phelip J, Nancey S, Flourie B.

Inflamm Bowel Dis. 2018 Apr 26. doi: 10.1093/ibd/izy111. [Epub ahead of print]

PMID:
29718216
12.

An onco-geriatric approach to select older patients for optimal treatments of pancreatic adenocarcinoma.

Castel-Kremer E, De Talhouet S, Charlois AL, Graillot E, Chopin-Laly X, Adham M, Comte B, Lombard-Bohas C, Walter T, Boschetti G.

J Geriatr Oncol. 2018 Jul;9(4):373-381. doi: 10.1016/j.jgo.2018.03.007. Epub 2018 Jun 9.

PMID:
29685381
13.

Predictive Models of Therapeutic Response to Vedolizumab: A Novel Step into Personalized Medicine in Crohn's Disease?

Veyrard P, Boschetti G, Nancey S, Roblin X.

Inflamm Bowel Dis. 2018 May 18;24(6):1193-1195. doi: 10.1093/ibd/izy033. No abstract available.

PMID:
29668995
14.

IBD-INFO Questionnaire: A Multicenter French Up-to-Date Survey of Patient Knowledge in Inflammatory Bowel Disease.

Danion P, Buisson A, Roblin X, Mathieu N, Charlois AL, Borgerding JN, Williet N, Del Tedesco E, Flourié B, Nancey S, Boschetti G.

Inflamm Bowel Dis. 2018 Apr 23;24(5):943-952. doi: 10.1093/ibd/izx073.

PMID:
29506217
15.

Update: Role of surgery in acute necrotizing pancreatitis.

El Boukili I, Boschetti G, Belkhodja H, Kepenekian V, Rousset P, Passot G.

J Visc Surg. 2017 Dec;154(6):413-420. doi: 10.1016/j.jviscsurg.2017.06.008. Epub 2017 Nov 4. Review.

PMID:
29113713
16.

Distinct Thresholds of Infliximab Trough Level Are Associated with Different Therapeutic Outcomes in Patients with Inflammatory Bowel Disease: A Prospective Observational Study.

Roblin X, Boschetti G, Duru G, Williet N, Deltedesco E, Phelip JM, Peyrin-Biroulet L, Nancey S, Flourié B, Paul S.

Inflamm Bowel Dis. 2017 Nov;23(11):2048-2053. doi: 10.1097/MIB.0000000000001223.

PMID:
28945636
17.

Fetal death in utero and miscarriage in a patient with Crohn's disease under therapy with ustekinumab: case-report and review of the literature.

Venturin C, Nancey S, Danion P, Uzzan M, Chauvenet M, Bergoin C, Roblin X, Flourié B, Boschetti G.

BMC Gastroenterol. 2017 Jun 19;17(1):80. doi: 10.1186/s12876-017-0633-6. Review.

18.

Death certificate data and causes of death in patients with parkinsonism.

Moscovich M, Boschetti G, Moro A, Teive HAG, Hassan A, Munhoz RP.

Parkinsonism Relat Disord. 2017 Aug;41:99-103. doi: 10.1016/j.parkreldis.2017.05.022. Epub 2017 May 26.

PMID:
28572021
19.

Azathioprine dose reduction in inflammatory bowel disease patients on combination therapy: an open-label, prospective and randomised clinical trial.

Roblin X, Boschetti G, Williet N, Nancey S, Marotte H, Berger A, Phelip JM, Peyrin-Biroulet L, Colombel JF, Del Tedesco E, Paul S, Flourie B.

Aliment Pharmacol Ther. 2017 Jul;46(2):142-149. doi: 10.1111/apt.14106. Epub 2017 Apr 27.

20.

Intestinal dendritic cell licensing through Toll-like receptor 4 is required for oral tolerance in allergic contact dermatitis.

Hacini-Rachinel F, Gomez de Agüero M, Kanjarawi R, Moro-Sibilot L, Le Luduec JB, Macari C, Boschetti G, Bardel E, Langella P, Dubois B, Kaiserlian D.

J Allergy Clin Immunol. 2018 Jan;141(1):163-170. doi: 10.1016/j.jaci.2017.02.022. Epub 2017 Mar 22.

PMID:
28342908
21.

Risk of Rectal Neoplasia after Colectomy and Ileorectal Anastomosis for Ulcerative Colitis.

Uzzan M, Kirchgesner J, Oubaya N, Amiot A, Gornet JM, Seksik P, Nancey S, Cotte E, Allez M, Boschetti G, Laharie D, de Angelis N, Nachury M, Pelletier AL, Abitbol V, Fumery M, Brouquet A, Buisson A, Altwegg R, Cosnes J, Panis Y, Treton X.

J Crohns Colitis. 2017 Aug 1;11(8):930-935. doi: 10.1093/ecco-jcc/jjx027.

PMID:
28333202
22.

Development and Internal Validation of a Model Using Fecal Calprotectin in Combination with Infliximab Trough Levels to Predict Clinical Relapse in Crohn's Disease.

Roblin X, Duru G, Williet N, Del Tedesco E, Cuilleron M, Jarlot C, Phelip JM, Boschetti G, Flourié B, Nancey S, Peyrin-Biroulet L, Paul S.

Inflamm Bowel Dis. 2017 Jan;23(1):126-132. doi: 10.1097/MIB.0000000000000986.

PMID:
28002129
23.

Postoperative Complications after Ileocecal Resection in Crohn's Disease: A Prospective Study From the REMIND Group.

Fumery M, Seksik P, Auzolle C, Munoz-Bongrand N, Gornet JM, Boschetti G, Cotte E, Buisson A, Dubois A, Pariente B, Zerbib P, Chafai N, Stefanescu C, Panis Y, Marteau P, Pautrat K, Sabbagh C, Filippi J, Chevrier M, Houze P, Jouven X, Treton X, Allez M; REMIND study group investigators.

Am J Gastroenterol. 2017 Feb;112(2):337-345. doi: 10.1038/ajg.2016.541. Epub 2016 Dec 13.

PMID:
27958285
24.

Association Between Low Trough Levels of Vedolizumab During Induction Therapy for Inflammatory Bowel Diseases and Need for Additional Doses Within 6 Months.

Williet N, Boschetti G, Fovet M, Di Bernado T, Claudez P, Del Tedesco E, Jarlot C, Rinaldi L, Berger A, Phelip JM, Flourie B, Nancey S, Paul S, Roblin X.

Clin Gastroenterol Hepatol. 2017 Nov;15(11):1750-1757.e3. doi: 10.1016/j.cgh.2016.11.023. Epub 2016 Nov 24.

PMID:
27890854
25.

Costs of Crohn's Disease According to Severity States in France: A Prospective Observational Study and Statistical Modeling over 10 Years.

Boschetti G, Nancey S, Daniel F, Pariente B, Lerebours E, Duclos B, Bourreille A, Cadiot G, Fumery M, Moreau J, Marteau P, Bouhnik Y, Louis E, Flourié B; GETAID.

Inflamm Bowel Dis. 2016 Dec;22(12):2924-2932.

26.

A Perioperative Clinical Pathway Can Dramatically Reduce Failure-to-rescue Rates After Cytoreductive Surgery for Peritoneal Carcinomatosis: A Retrospective Study of 666 Consecutive Cytoreductions.

Passot G, Vaudoyer D, Villeneuve L, Wallet F, Beaujard AC, Boschetti G, Rousset P, Bakrin N, Cotte E, Glehen O.

Ann Surg. 2017 Apr;265(4):806-813. doi: 10.1097/SLA.0000000000001723.

PMID:
27775553
27.

Accuracies of fecal calprotectin, lactoferrin, M2-pyruvate kinase, neopterin and zonulin to predict the response to infliximab in ulcerative colitis.

Frin AC, Filippi J, Boschetti G, Flourie B, Drai J, Ferrari P, Hebuterne X, Nancey S.

Dig Liver Dis. 2017 Jan;49(1):11-16. doi: 10.1016/j.dld.2016.09.001. Epub 2016 Sep 13.

PMID:
27693318
28.

Gut Inflammation in Mice Triggers Proliferation and Function of Mucosal Foxp3+ Regulatory T Cells but Impairs Their Conversion from CD4+ T Cells.

Boschetti G, Kanjarawi R, Bardel E, Collardeau-Frachon S, Duclaux-Loras R, Moro-Sibilot L, Almeras T, Flourié B, Nancey S, Kaiserlian D.

J Crohns Colitis. 2017 Jan;11(1):105-117. doi: 10.1093/ecco-jcc/jjw125. Epub 2016 Jun 30.

PMID:
27364948
29.

Octave Bias in Pitch Perception: The Influence of Pitch Height on Pitch Class Identification.

Prpic V, Murgia M, De Tommaso M, Boschetti G, Galmonte A, Agostini T.

Perception. 2016 Sep;45(9):1060-9. doi: 10.1177/0301006616651953. Epub 2016 May 31.

PMID:
27251169
30.

Intima-media thickness remodelling in hypertensive subjects with long-term well-controlled blood pressure levels.

Puato M, Boschetti G, Rattazzi M, Zanon M, Pesavento R, Faggin E, Fania C, Benetti E, Palatini P, Pauletto P.

Blood Press. 2017 Feb;26(1):48-53. doi: 10.1080/08037051.2016.1184964. Epub 2016 May 24.

PMID:
27216375
31.

Mouse and Human Liver Contain Immunoglobulin A-Secreting Cells Originating From Peyer's Patches and Directed Against Intestinal Antigens.

Moro-Sibilot L, Blanc P, Taillardet M, Bardel E, Couillault C, Boschetti G, Traverse-Glehen A, Defrance T, Kaiserlian D, Dubois B.

Gastroenterology. 2016 Aug;151(2):311-23. doi: 10.1053/j.gastro.2016.04.014. Epub 2016 Apr 27.

PMID:
27132185
32.

Isolated ileitis associated with primary sclerosing cholangitis in three patients with Crohn's disease.

Moussata D, Boschetti G, Stefanescu C, Nancey S, Bouhnik Y, Flourie B.

Scand J Gastroenterol. 2016;51(6):727-30. doi: 10.3109/00365521.2015.1126634. Epub 2016 Jan 25.

PMID:
26806276
33.

Patients with Peritoneal Carcinomatosis from Gastric Cancer Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Is Cure a Possibility?

Chia CS, You B, Decullier E, Vaudoyer D, Lorimier G, Abboud K, Bereder JM, Arvieux C, Boschetti G, Glehen O; BIG RENAPE Group.

Ann Surg Oncol. 2016 Jun;23(6):1971-9. doi: 10.1245/s10434-015-5081-3. Epub 2016 Jan 11.

PMID:
26753751
34.

Enrichment of Circulating and Mucosal Cytotoxic CD8+ T Cells Is Associated with Postoperative Endoscopic Recurrence in Patients with Crohn's Disease.

Boschetti G, Nancey S, Moussata D, Cotte E, Francois Y, Flourié B, Kaiserlian D.

J Crohns Colitis. 2016 Mar;10(3):338-45. doi: 10.1093/ecco-jcc/jjv211. Epub 2015 Nov 19.

35.

Plasmacytoid dendritic cells are dispensable for noninfectious intestinal IgA responses in vivo.

Moro-Sibilot L, This S, Blanc P, Sanlaville A, Sisirak V, Bardel E, Boschetti G, Bendriss-Vermare N, Defrance T, Dubois B, Kaiserlian D.

Eur J Immunol. 2016 Feb;46(2):354-9. doi: 10.1002/eji.201545977. Epub 2015 Nov 23.

36.

Parakinesia Brachialis Oscitans: A Case Report.

Farah M, Barcellos I, Boschetti G, Munhoz RP.

Mov Disord Clin Pract. 2015 Sep 16;2(4):436-437. doi: 10.1002/mdc3.12234. eCollection 2015 Dec. No abstract available.

37.

Response to Dai et al.

Boschetti G, Drai J, Flourié B, Nancey S.

Am J Gastroenterol. 2015 Aug;110(8):1242. doi: 10.1038/ajg.2015.199. No abstract available.

PMID:
26263365
38.

A challenging case of multiple splenic and pancreatic lesions in a patient with Crohn's disease.

Boschetti G, Assaad S, Balme B, Boyer S, Flourié B, Nancey S.

Gut. 2016 Feb;65(2):295, 312. doi: 10.1136/gutjnl-2015-310130. Epub 2015 Aug 5. No abstract available.

PMID:
26246245
39.

Association of Anti-glycan Antibodies and Inflammatory Bowel Disease Course.

Paul S, Boschetti G, Rinaudo-Gaujous M, Moreau A, Del Tedesco E, Bonneau J, Presles E, Mounsef F, Clavel L, Genin C, Flourié B, Phelip JM, Nancey S, Roblin X.

J Crohns Colitis. 2015 Jun;9(6):445-51. doi: 10.1093/ecco-jcc/jjv063. Epub 2015 Apr 19.

PMID:
25895876
40.

GRECCAR 8: impact on survival of the primary tumor resection in rectal cancer with unresectable synchronous metastasis: a randomized multicentre study.

Cotte E, Villeneuve L, Passot G, Boschetti G, Bin-Dorel S, Francois Y, Glehen O; French Research Group of Rectal Cancer Surgery (GRECCAR).

BMC Cancer. 2015 Feb 12;15:47. doi: 10.1186/s12885-015-1060-0.

41.

Abdominal necrotic abscess from colonic fistula treated endoscopically.

Petit B, Boschetti G, Passot G, Chauvenet M, Cotte E, Stroeymeyt K, Nancey S, Vaudoyer D, François Y, Cabelguenne D, Glehen O, Flourié B, Moussata D.

Gastrointest Endosc. 2015 Apr;81(4):1026-7. doi: 10.1016/j.gie.2014.10.043. No abstract available.

PMID:
25805472
42.

Levels of Fecal Calprotectin Are Associated With the Severity of Postoperative Endoscopic Recurrence in Asymptomatic Patients With Crohn's Disease.

Boschetti G, Laidet M, Moussata D, Stefanescu C, Roblin X, Phelip G, Cotte E, Passot G, Francois Y, Drai J, Del Tedesco E, Bouhnik Y, Flourie B, Nancey S.

Am J Gastroenterol. 2015 Jun;110(6):865-72. doi: 10.1038/ajg.2015.30. Epub 2015 Mar 17.

PMID:
25781366
43.

Endoscopic and histologic characteristics of serrated lesions.

Moussata D, Boschetti G, Chauvenet M, Stroeymeyt K, Nancey S, Berger F, Lecomte T, Flourié B.

World J Gastroenterol. 2015 Mar 14;21(10):2896-904. doi: 10.3748/wjg.v21.i10.2896. Review.

44.

Accuracies of serum and fecal S100 proteins (calprotectin and calgranulin C) to predict the response to TNF antagonists in patients with Crohn's disease.

Boschetti G, Garnero P, Moussata D, Cuerq C, Préaudat C, Duclaux-Loras R, Mialon A, Drai J, Flourié B, Nancey S.

Inflamm Bowel Dis. 2015 Feb;21(2):331-6. doi: 10.1097/MIB.0000000000000273.

PMID:
25625487
45.

Tacrolimus induction followed by maintenance monotherapy is useful in selected patients with moderate-to-severe ulcerative colitis refractory to prior treatment.

Boschetti G, Nancey S, Moussata D, Stefanescu C, Roblin X, Chauvenet M, Stroeymeyt K, Bouhnik Y, Flourié B.

Dig Liver Dis. 2014 Oct;46(10):875-80. doi: 10.1016/j.dld.2014.06.005. Epub 2014 Jul 8.

PMID:
25023007
46.

Pathological response to neoadjuvant chemotherapy: a new prognosis tool for the curative management of peritoneal colorectal carcinomatosis.

Passot G, You B, Boschetti G, Fontaine J, Isaac S, Decullier E, Maurice C, Vaudoyer D, Gilly FN, Cotte E, Glehen O.

Ann Surg Oncol. 2014 Aug;21(8):2608-14. doi: 10.1245/s10434-014-3647-0. Epub 2014 Mar 26.

PMID:
24668148
47.

GASTRICHIP: D2 resection and hyperthermic intraperitoneal chemotherapy in locally advanced gastric carcinoma: a randomized and multicenter phase III study.

Glehen O, Passot G, Villeneuve L, Vaudoyer D, Bin-Dorel S, Boschetti G, Piaton E, Garofalo A.

BMC Cancer. 2014 Mar 14;14:183. doi: 10.1186/1471-2407-14-183.

48.

Cognitive Functions across the GNB3 C825T Polymorphism in an Elderly Italian Population.

Casiglia E, Giordano N, Tikhonoff V, Boschetti G, Mazza A, Caffi S, Guidotti F, Bisiacchi P.

Neurol Res Int. 2013;2013:597034. doi: 10.1155/2013/597034. Epub 2013 Oct 22.

49.

Precompetitive assessment of heart rate variability in elite female athletes during play offs.

D'Ascenzi F, Alvino F, Natali BM, Cameli M, Palmitesta P, Boschetti G, Bonifazi M, Mondillo S.

Clin Physiol Funct Imaging. 2014 May;34(3):230-6. doi: 10.1111/cpf.12088. Epub 2013 Oct 1.

PMID:
24112387
50.

Orthostatic hypotension does not increase cardiovascular risk in the elderly at a population level.

Casiglia E, Tikhonoff V, Caffi S, Boschetti G, Giordano N, Guidotti F, Segato F, Mazza A, Grasselli C, Saugo M, Rigoni G, Guglielmi F, Martini B, Palatini P.

Am J Hypertens. 2014 Jan;27(1):81-8. doi: 10.1093/ajh/hpt172. Epub 2013 Sep 23.

PMID:
24061072

Supplemental Content

Loading ...
Support Center